In this episode, I talked with Dr. Kevin Heller, former biotech CMO and now advisor to VCs and funds, who’s built his career at the intersection of science, leadership, and investment. Kevin started out as a pediatric hematologist–oncologist before joining BMS, where he worked on one of the first checkpoint inhibitor programs. Since then, he’s held senior roles across biotech and now works closely with companies and investors on strategy.

Kevin opened up about the habits that nearly held him back early in his career, how a colleague’s honest feedback changed the way he leads, and why the quiet moments in meetings often say more about culture than the loud ones.

He also shared about today’s funding climate—why raising money feels tougher than ever, what investors really look for, and why every company needs a clear plan for when things don’t go as expected. And outside of biotech, Kevin’s focus is on mentoring the next generation of scientists through the Society for Science, an organization he’s been deeply involved with for years.

Here’s What You’re In For

• The subtle warning signs of a weak culture (and why silence is the biggest one)
• The kind of questions investors ask now that many companies aren’t ready for
• How mentoring young scientists through the Society for Science has become Kevin’s way of giving back

Timestamps

00:58 – How Kevin moved from academia into industry

06:00 – The colleague who bluntly told him to be quiet

10:20 – What Kevin has seen change in biotech fundraising over the past few years

12:34 – The advice he gives to early-stage companies heading into investor meetings

16:15 – What most outsiders don’t realize about being on the investment side

17:54 – What “culture” actually means to him, and why bad leadership kills it

20:14 – The subtle early signs of a broken culture: silence in meetings

26:48 – Kevin’s involvement with the Society for Science and mentoring future scientists

About Kevin

Kevin Heller is a former biotech CMO and a current advisor to funds and VCs. He serves as Investment Team Advisor at an equity fund investing in biotech. He is a Pediatric Hematologist/Oncologist, and began his career at BMS where he contributed to the development of YUR-VOY.

He has held CMO roles at several biotech companies, worked on numerous early-stage programs (including at Incyte), and continues to influence the field through his advisory roles.

Kevin serves as a mentor, judge, and council member of Society for Science, a nonprofit that promotes science literacy and runs major student science fairs worldwide, in his way of giving back to the mentors who guided him early in his career. For him, it’s about inspiring the next generation to see science as something they can own and shape.

Connect with Kevin:

• LinkedIn: https://www.linkedin.com/in/kevin-n-heller-8bbb985/
• Society for Science:https://www.societyforscience.org/

About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment, I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East